These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 22759202

  • 1. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L, Zeng F, Zong L.
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [Abstract] [Full Text] [Related]

  • 2. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C, Prabhakar B.
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [Abstract] [Full Text] [Related]

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 4. Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydroxypropyl-β-cyclodextrin inclusion complexes.
    Zeng F, Wang L, Zhang W, Shi K, Zong L.
    AAPS PharmSciTech; 2013 Jun; 14(2):854-60. PubMed ID: 23649995
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of orally disintegrating tablets of perphenazine/hydroxypropyl-beta-cyclodextrin inclusion complex in rabbits.
    Wang L, Xiao YY, Chen ML, Zeng F, Zong L.
    Pharmazie; 2013 Oct; 68(10):800-4. PubMed ID: 24273883
    [Abstract] [Full Text] [Related]

  • 6. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
    Lv HX, Zhang ZH, Hui-Jiang, Waddad AY, Zhou JP.
    Pharmazie; 2012 Jan; 67(1):46-53. PubMed ID: 22393830
    [Abstract] [Full Text] [Related]

  • 7. Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability.
    Desai S, Poddar A, Sawant K.
    Mater Sci Eng C Mater Biol Appl; 2016 Jan 01; 58():826-34. PubMed ID: 26478377
    [Abstract] [Full Text] [Related]

  • 8. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun 01; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
    Kou W, Cai C, Xu S, Wang H, Liu J, Yang D, Zhang T.
    Int J Pharm; 2011 May 16; 409(1-2):75-80. PubMed ID: 21371541
    [Abstract] [Full Text] [Related]

  • 10. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W, Akkaramongkolporn P, Ngawhirunpat T, Rojanarata T, Opanasopit P.
    Drug Dev Ind Pharm; 2015 Jun 16; 41(6):1006-16. PubMed ID: 24865111
    [Abstract] [Full Text] [Related]

  • 11. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Wang S, Ding Y, Yao Y.
    Drug Dev Ind Pharm; 2009 Jul 16; 35(7):808-13. PubMed ID: 19337873
    [Abstract] [Full Text] [Related]

  • 12. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R, Madan J, Kaushik D, Sardana S, Pandey RS, Sharma R.
    Pharm Dev Technol; 2013 Jul 16; 18(2):313-22. PubMed ID: 21699389
    [Abstract] [Full Text] [Related]

  • 13. Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation.
    Laitinen R, Suihko E, Bjorkqvist M, Riikonen J, Lehto VP, Jarvinen K, Ketolainen J.
    Drug Dev Ind Pharm; 2010 May 16; 36(5):601-13. PubMed ID: 19954406
    [Abstract] [Full Text] [Related]

  • 14. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV, Chotai NP, Patel MP.
    Pharmazie; 2008 Apr 16; 63(4):275-81. PubMed ID: 18468386
    [Abstract] [Full Text] [Related]

  • 15. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M, Cao W, Sun Y, He Z.
    Int J Pharm; 2014 Dec 30; 477(1-2):159-66. PubMed ID: 25455768
    [Abstract] [Full Text] [Related]

  • 16. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł, Kasperek R, Poleszak E.
    Polim Med; 2014 Dec 30; 44(4):231-5. PubMed ID: 25932904
    [Abstract] [Full Text] [Related]

  • 17. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV, Kotak DJ, Degani MS, Kirsanov D, Legin A, Devarajan PV.
    AAPS PharmSciTech; 2017 Aug 30; 18(6):2055-2066. PubMed ID: 27995465
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
    Taneri F, Ozcan I, Guneri T.
    Drug Deliv; 2010 Apr 30; 17(3):152-7. PubMed ID: 20148713
    [Abstract] [Full Text] [Related]

  • 19. Studies on formulation development of mouth dissolving tablets of Carvedilol.
    Pokharkar V, Dhar S, Mandpe L.
    Hindustan Antibiot Bull; 2010 Apr 30; 49-50(1-4):21-8. PubMed ID: 19957540
    [Abstract] [Full Text] [Related]

  • 20. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X, Zhang T, Lan Y, Wu B, Shi Z.
    AAPS PharmSciTech; 2016 Apr 30; 17(2):400-8. PubMed ID: 26187778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.